NanoPass Technologies, J&J deal

Johnson & Johnson's Janssen Pharmaceuticals Inc. received exclusive rights to use NanoPass' MicronJet microneedle intradermal delivery device for use in Janssen's seasonal influenza programs. Janssen ...